MarketsandMarkets Presents
Protein Binding Assays Market worth $425.7 million in 2023
https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
The report The report "Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023", The global protein binding assays market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7%. Browse: 63 market data tables 21 figures 97 pages And in-depth TOC on ÍžProtein Binding Assays MarketÍ&#x; Download The PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=44025612
The increasing use of protein binding assays in pre-clinical research for studying the distribution properties of the drug, and the growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical
R&D expenditure is driving the growth of this market. https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
Drivers • Rise in Drug Discovery Activities • Growing Pressure to Reduce Drug Discovery and Development Costs
• Increase in Pharmaceutical R&D Expenditure Talk to Our Research Experts@ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=44025612 Restraints • Issues With Existing Technologies Opportunities • Growing CRO Industry Challenges • Development of in Silico-Based Prediction Models
https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
Based on technology, equilibrium dialysis segment is expected to grow at the highest CAGR in the market during the forecast period
On the basis of technology, the global protein binding assays market is divided into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies.
In 2018, the equilibrium dialysis segment is expected to grow at the highest CAGR in the protein binding assays market. The growth can be attributed to the tech i ue’s physical simplicity, low cost, and high accuracy. It is also considered as a gold standard technique
for protein binding studies.
Based on end user, Contract Research Organizations (CROs) segment is expected to grow at the highest CAGR in the market during the forecast period https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
On the basis of end user, the global protein binding assays market is divided into pharmaceutical and biotechnology companies, CROs, and other end users. In 2018, the CROs segment is expected to grow at the highest CAGR in the global protein binding assays market. This high growth can be attributed to the increase increased protein binding studies for drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biologics. Asia Pacific is expected to grow at the highest CAGR during the forecast period
The APAC market is projected to register the highest growth rate during the forecast period primarily due to factors such as, growth of clinical trial activities in several APAC countries. As a result of this, the pharmaceutical and biopharmaceutical companies are outsourcing their drug discovery and development activities to APAC-based CROs. This is one of the major factors driving the growth of the protein binding assay market in the Asia Pacific. Market Players The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany). https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
About MarketsandMarkets™ Ma ketsa dMa kets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Ma ketsa dMa kets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Ma ketsa dMa kets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Ma ketsa dMa kets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. Ma ketsa dMa kets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. Ma ketsa dMa kets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
https://www.marketsandmarkets.com/Market-Reports/protein-binding-assay-market44025612.html
Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets